• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Incidence of SARS-CoV-2 Seropositivity in Pediatric Healthcare Workers Prior to Widespread Vaccination: A Five-month Longitudinal

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2024 Apr 17:107064.
doi: 10.1016/j.ijid.2024.107064. Online ahead of print. Incidence of SARS-CoV-2 Seropositivity in Pediatric Healthcare Workers Prior to Widespread Vaccination: A Five-month Longitudinal Cohort Study

Mark Griffiths[SUP] 1 [/SUP], Dunia Hatabah[SUP] 2 [/SUP], Patrick Sullivan[SUP] 3 [/SUP], Grace Mantus[SUP] 2 [/SUP], Travis Sanchez[SUP] 3 [/SUP], Maria Zlotorzynska[SUP] 3 [/SUP], Stacy Heilman[SUP] 2 [/SUP], Andres Camacho-Gonzalez[SUP] 4 [/SUP], Deborah Leake[SUP] 5 [/SUP], Rawan Korman[SUP] 2 [/SUP], Mimi Le[SUP] 6 [/SUP], Mehul Suthara[SUP] 7 [/SUP], Jens Wrammert[SUP] 8 [/SUP], Miriam B Vos[SUP] 9 [/SUP], Claudia R Morris[SUP] 10 [/SUP]



Affiliations
Abstract

Objectives: Determine SARS-CoV-2 IgG antibody incidence over time in unvaccinated pediatric healthcare workers (pHCWs).
Design: Prospective longitudinal cohort of unvaccinated pHCWs measuring incidence of new infection after initial prevalence was established at 4.1% with seropositive predominance in emergency department (ED)-based pHCWs. Serum samples were collected at follow-up visits to detect new SARS-CoV-2 seropositivity. Univariate analysis was performed to estimate different incidence rates between participant demographics, job, employment location and community risk factors. Anxiety levels about COVID-19 were collected. SARS-CoV-2 antibody decay post-infection, and neutralization antibodies were evaluated. Log-linear Poisson regression models were used to estimate incidence.
Results: Of 642 initially enrolled, 390 pHCWs presented for at least one follow-up serology test after baseline analysis. Incidence of SARS-CoV-2 seropositivity was 8.2%. The seropositive cohort, like the negative one consisted mainly of females in non-ED settings and non-physician roles. There were no statistically significant differences in incidence across variables. Seropositive participants dropped antibody titers by 50% at 3 months. Neutralization antibodies correlated to SARs-CoV-2 binding antibodies (r=0.43,p<0.0001).
Conclusion: Incidence of seropositivity was 8.2%. Although seropositivity was higher among ED staff during early stages of the pandemic, this difference declined over time, likely due to universal adoption of personal protective equipment (PPE).

Keywords: COVID-19; Emergency Department; Neutralization Antibodies; Personal Protective Equipment; Receptor Binding Domain; SARS-CoV-2; SARS-CoV-2 IgG Antibodies; pediatric healthcare workers.

 
Back
Top Bottom